Study: Neuropathy Frequently enough Undiagnosed,⁣ linked to Metabolic Syndrome

Updated May 08, 2024
⁢

A recent study published in Neurology highlights the prevalence⁤ of undiagnosed neuropathy, a condition causing nerve damage that leads to⁢ pain, numbness, and potential complications⁤ like ‍falls and infections. The research emphasizes the link between ⁣neuropathy and metabolic syndrome, particularly among medicaid patients.

Dr.Melissa ⁢A. Elafros, of the University⁢ of⁢ Michigan, lead author of the study, stated that over a third of neuropathy sufferers experiance sharp, prickling, or shock-like pain, ⁤which can lead to depression and a reduced quality of life. She added that identifying and treating individuals at risk for neuropathy is essential, given the increased risk of earlier death associated with the condition.

The study focused on 169 patients ⁣from ⁣a Flint, Michigan, internal medicine clinic, with ⁢an average age of 58. A majority (69%) were Black, and half had diabetes, a known cause of neuropathy. moreover, 67% presented with metabolic syndrome, ⁣characterized by excess abdominal fat and at least two risk factors, including high blood pressure, elevated triglycerides, high blood⁣ sugar, and low HDL cholesterol.

Researchers tested all participants for distal symmetric ⁤polyneuropathy and ‍gathered⁢ data on their‍ overall health. The results showed that 73% had neuropathy, with 75% of those cases previously undiagnosed. Nearly 60% of those⁢ with nerve damage experienced ‍pain.

The study⁢ also ⁣revealed that⁣ 74% of neuropathy patients had metabolic syndrome, compared to⁣ 54% without neuropathy. After adjusting for other potential risk factors, the researchers concluded that individuals with metabolic syndrome were more ⁢than four⁢ times more likely to have neuropathy.

While the ⁣study found no ⁤direct correlation between low income⁣ and ⁣neuropathy, it did note a decreased⁣ risk among Black participants. Black individuals comprised 60% of the neuropathy group and 91% of the non-neuropathy group.

Elafros emphasized the exceptionally high rate of neuropathy, particularly‍ undiagnosed cases, within⁤ the ⁣study population. She called for urgent interventions to improve diagnosis and management, along with strategies to address the risk factors contributing to⁢ the‍ condition.the study was limited by its cross-sectional design and did not explore the reasons behind the mismanagement of neuropathy risk factors.

What’s next

Further research is needed to understand ‍the long-term ‍effects of metabolic‍ syndrome on neuropathy advancement and to identify effective strategies for early diagnosis and intervention.